So many of the "insiders" on this board say Praluent will flop. Thomson Reuters predict it to be a $4 billion drug by 2019. Who's right and who's wrong? I have a tendency to lean with the pro's at Thomson Reuters. I also think the guys at Regeneron and Sanofi know what they are doing as well.
It seems like almost every post on every board says their company is gonna flop and is terrible. The bottom line is the company is gonna look out for the company and if you suck you will be fired.
It seems like almost every post on every board says their company is gonna flop and is terrible. The bottom line is the company is gonna look out for the company and if you suck you will be fired.